Geode Capital Management’s Mateon Therapeutics, Inc. MATN Stock Holding History

Geode Capital Management’s Portfolio MATN Stock Details MATN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-60,393	Closed	-$37K	–	4073
2016 Q3	$37K	Hold	60,393	–	–	﹤0.01%	3946
2016 Q2	$42K	Buy	+60,393	New	+$42.8K	﹤0.01%	3956

Other funds holding MATN

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Geode Capital Management's MATN Position: Q4 2016 in Review

Geode Capital Management sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 60,393 shares — an estimated $37K sold.

Geode Capital Management first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $42K in Q2 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

Geode Capital Management reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
Geode Capital Management sold 60,393 Mateon Therapeutics, Inc. shares in Q4 2016, an estimated $37K.
Geode Capital Management first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
Geode Capital Management's Mateon Therapeutics, Inc. position peaked at $42K in Q2 2016.
1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.

Based on Geode Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.